Stock TRI TRIVARX LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News TrivarX Limited

Equities

TRI

AU0000300196

End-of-day quote Australian S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.026 AUD +4.00% Intraday chart for TrivarX Limited +13.04% -13.33%
Feb. 28 TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Feb. 09 TrivarX Signs Collaboration with Northern Michigan University on Sleep Research MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
TrivarX Signs Collaboration with Northern Michigan University on Sleep Research
MT
TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%
MT
Over Half of Patients On Track for Completion in TrivarX's SAMDE Study
MT
Reverse Split: 1 of 20
FA
TrivarX Undertaking 1-for-20 Securities Consolidation
MT
Medibio Limited has Changed its Name to TrivarX Limited
CI
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director
CI
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director
CI
Medibio Begins Phase Two Trial for Sleep Algorithm
MT
TrivarX Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Medibio Completes Phase One Depressive Episode Sleep Trial
MT
US FDA Denies Breakthrough Device Designation for Medibio’s Depression Diagnostic Device
MT
Medibio Completes Shares Purchase Plan
MT
Medibio Adds Executive Director Role to CEO, Changes Principal Pace of Business
MT
Medibio Limited Announces Board & Management Changes
CI
Medibio Limited Announces Change of Registered Office and Principal Place of Business
CI
Medibio Limited Announces Resignation of Matt Mesnik as Non-Executive Director
CI
Medibio Limited Lodges Breakthrough Device Designation with FDA
CI
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRI Stock
  4. News TrivarX Limited